drugset

drugset / Trial / NCT00364702

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

NCT00364702 ↗

Phase 2 Completed 40 enrolled Shaare Zedek Medical Center

Non-randomizedFactorialOpen-labelDiagnostic

Summary

Using a virtual reality program in screening and treatment of ADHD.

Timeline

Start: 2006-08
Primary completion: 2007-07
Completion: 2007-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Methylphenidate	Small molecule	1 mg/kg	—

Indications